Moderna stock was falling on Thursday after the company reported a first-quarter loss and a slide in revenue and laid out ...

Biotechnology company Moderna (NASDAQ:MRNA) will be announcing earnings results tomorrow before market hours. Here’s what you ...

We recently published a list of the 11 Worst Performing Stocks in S&P 500 So Far in 2025. In this article, we will take a ...

In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...

The major stock indices rose as investors ... Moderna shares may have faced additional pressures amidst general concerns about economic growth and... Moderna (NasdaqGS:MRNA) recently experienced a 17% ...

Moderna (Nasdaq: MRNA) said in the filing that the goal was “to retain and motivate these key leaders, particularly in light of the decline in our stock price.” The value of the pay packages ...

the company's price move was notably larger than the overall market increase of 4%. Such outperformance could have been... Moderna stock and other vaccine makers are under pressure after Peter ...

1 Day MRNA 0.93% DJIA 1.65% S&P 500 2.13% Health Care/Life Sciences -0.59% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

As mentioned, Moderna reached stardom in the early pandemic days, generating billions of dollars in earnings, thanks to its coronavirus vaccine. And the stock price followed, advancing more than ...

Berenberg Bank boosted their price objective on Moderna from $33.00 to $42.00 and gave the stock a “hold” rating in a research note on Thursday, January 16th. Leerink Partners lowered their ...

The stock led S&P 500 decliners on Monday, falling 8.9% to $28.35. Below, we take a closer look at the technicals on Moderna’s weekly chart and identify key price levels that investors may be ...

During this period, the Zacks Medical - Biomedical and Genetics industry, which Moderna falls in, has lost 0.6%. The key question now is: What could be the stock's future direction? While media ...